AccScience Publishing / HM / Online First / DOI: 10.36922/HM026340011
Cite this article
1
Download
25
Views
Related Info Links
More by Authors Links
Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
REVIEW ARTICLE

Three-dimensional bioprinting strategies for oxygen gradient control and precision cancer therapy

Yixing Zhang1,2 ,  Yujie Wei1,2 ,  Zaile Zhou1,2 ,  Yiwei Men2 ,  Rudan Chang2 ,  Jinhai Deng5 ,  Lifeng Li1,2,3,4* ,  Jie Zhao1,2*
Show Less
1 Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan , China
2 National Engineering Laboratory for Internet Medical Systems and Applications, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan , China
3 Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan , China
4 Medical School, Huanghe Science and Technology University, Zhengzhou, Henan , China
5 Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King’s College London , United Kingdom
Received: 17 August 2026 | Revised: 19 September 2026 | Accepted: 14 October 2026 | Published online: 19 November 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC-by the license) ( https://creativecommons.org/licenses/by-nc/4.0/ )
Abstract

Tumor hypoxia is spatially and temporally heterogeneous and contributes to metabolic adaptation, invasion, and treatment resistance. Although three-dimensional cultures can develop oxygen gradients spontaneously, their magnitude and stability are often poorly controlled. Three-dimensional bioprinting can prescribe cell density, diffusion distance, matrix composition, vascular geometry, and oxygen-modulating components. This review compares geometry-driven, material-mediated, and perfusion-based oxygen control, distinguishing direct evidence from bioprinted tumor constructs from hybrid fabrication studies and non-bioprinted transport or biological benchmarks. A semi-quantitative design map links engineering parameters to oxygen outcomes, recommended measurements, and confounders. We examine how these oxygen environments relate to hypoxia-inducible factor signaling, metabolism, stromal interactions, and responses to chemotherapy and radiotherapy. Measurement methods are compared according to the quantity measured, spatial and temporal sampling, calibration, and biological specificity. Patient-derived model establishment and reported ex vivo–clinical response concordance support further translation. The next step is to test whether explicit oxygen engineering improves treatment prediction in matched model comparisons. We propose an iterative workflow connecting target oxygen specifications, fabrication, spatial and longitudinal validation, and treatment testing.

Keywords
3D bioprinting
Tumor hypoxia
Metabolic reprogramming
Patient-derived tumor model
Personalized oncology
Funding
This work was supported by the National Natural Science Foundation of China (grant no. 32370976), the Funding for Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University (grant no. ZYCXTD2023005), and the Wu Jieping Medical Foundation Special Fund for Targeted Cancer Research (grant no. 320.6750.2023-02-1).
Conflict of interest
The authors declare no conflicts of interest.
References

Abedi, K., Sissoko, C., Pun, S., Kappagantula, S., Zucca, B., & Barrile, R. (2026). Modeling glioblastoma niche-by-niche: Recent advancements in bioengineering of organotypic models of glioblastoma for precision medicine. Biofabrication, 18(3), 032004. https://doi.org/10.1088/1758-5090/ae7832

 

Aguilera-Marquez, J. D. R., Manzanares-Guzmán, A., García-Uriostegui, L., Canales-Aguirre, A. A., Camacho-Villegas, T. A., & Lugo-Fabres, P. H. (2025). Alginate–gelatin hydrogel scaffold model for hypoxia induction in glioblastoma embedded spheroids. Gels, 11(4), 263. https://doi.org/10.3390/gels11040263

 

Anderson, N. M., & Simon, M. C. (2020). The tumor microenvironment. Current Biology, 30(16), R921-R925. https://doi.org/10.1016/j.cub.2020.06.081

 

Ayuso, J. M., Monge, R., Martínez-González, A., Virumbrales-Muñoz, M., Llamazares, G. A., Berganzo, J., Hernández-Laín, A., Santolaria, J., Doblaré, M., Hubert, C., Rich, J. N., Sánchez-Gómez, P., Pérez-García, V. M., Ochoa, I., & Fernández, L. J. (2017). Glioblastoma on a microfluidic chip: Generating pseudopalisades and enhancing aggressiveness through blood vessel obstruction events. Neuro-Oncology, 19(4), 503–513. https://doi.org/10.1093/neuonc/now230

 

Bader, S. B., Dewhirst, M. W., & Hammond, E. M. (2020). Cyclic hypoxia: An update on its characteristics, methods to measure it and biological implications in cancer. Cancers (Basel), 13(1), 23. https://doi.org/10.3390/cancers13010023

 

Blanco-Fernandez, B., Rey-Vinolas, S., Bağcı, G., Rubi-Sans, G., Otero, J., Navajas, D., Perez-Amodio, S., & Engel, E. (2022). Bioprinting decellularized breast tissue for the development of three-dimensional breast cancer models. ACS Applied Materials & Interfaces, 14(26), 29467–29482. https://doi.org/10.1021/acsami.2c00920

 

Bock, N., Forouz, F., Hipwood, L., Clegg, J., Jeffery, P., Gough, M., van Wyngaard, T., Pyke, C., Adams, M. N., Bray, L. J., Croft, L., Thompson, E. W., Kryza, T., & Meinert, C. (2023). GelMA, click-chemistry gelatin and bioprinted polyethylene glycol-based hydrogels as 3D ex vivo drug testing platforms for patient-derived breast cancer organoids. Pharmaceutics, 15(1), 261. https://doi.org/10.3390/pharmaceutics15010261

 

Brown, J. M., & Wilson, W. R. (2004). Exploiting tumour hypoxia in cancer treatment. Nature Reviews Cancer, 4(6), 437–447. https://doi.org/10.1038/nrc1367

 

Burkholder-Wenger, A. C., Golzar, H., Wu, Y., & Tang, X. S. (2022). Development of a hybrid nanoink for 3D bioprinting of heterogeneous tumor models. ACS Biomaterials Science & Engineering, 8(2), 777–785. https://doi.org/10.1021/acsbiomaterials.1c01265

 

Calabretta, M. M., Ferri, M., Tassoni, A., Maiello, S., & Michelini, E. (2024). Novel bioassays based on 3D-printed device for sensing of hypoxia and p53 pathway in 3D cell models. Analytical and Bioanalytical Chemistry, 416(29), 6819–6826. https://doi.org/10.1007/s00216-024-05606-0

 

Chaturvedi, P., Gilkes, D. M., Wong, C. C. L., Kshitiz, Luo, W., Zhang, H., Wei, H., Takano, N., Schito, L., Levchenko, A., & Semenza, G. L. (2013). Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis. Journal of Clinical Investigation, 123(1), 189–205. https://doi.org/10.1172/jci64993

 

Chen, A., Sceneay, J., Gödde, N., Kinwel, T., Ham, S., Thompson, E. W., Humbert, P. O., & Möller, A. (2018). Intermittent hypoxia induces a metastatic phenotype in breast cancer. Oncogene, 37(31), 4214–4225. https://doi.org/10.1038/s41388-018-0259-3

 

Chen, H., Du, L., Li, J., Wu, Z., Gong, Z., Xia, Y., Fan, Z., Qian, Q., Ding, Z., Hu, H., & Guo, S. (2022). Modeling cancer metastasis using acoustically bio-printed patient-derived 3D tumor microtissues. Journal of Materials Chemistry B, 10(11), 1843–1852. https://doi.org/10.1039/d1tb02789a

 

Chermat, R., Refet-Mollof, E., Kamio, Y., Carrier, J. F., Wong, P., & Gervais, T. (2024). Brachytherapy on-a-chip: A clinically-relevant approach for radiotherapy testing in 3d biology. Lab on a Chip, 24(8), 2335–2346. https://doi.org/10.1039/d4lc00032c

 

Dankó, T., Petővári, G., Raffay, R., Sztankovics, D., Moldvai, D., Vetlényi, E., Krencz, I., Rókusz, A., Sipos, K., Visnovitz, T., Pápay, J., & Sebestyén, A. (2022). Characterisation of 3D bioprinted human breast cancer model for in vitro drug and metabolic targeting. International Journal of Molecular Sciences, 23(13), 7444. https://doi.org/10.3390/ijms23137444

 

de Heer, E. C., Jalving, M., & Harris, A. L. (2020). Hifs, angiogenesis, and metabolism: Elusive enemies in breast cancer. Journal of Clinical Investigation, 130(10), 5074–5087. https://doi.org/10.1172/jci137552

 

Desigaux, T., Comperat, L., Dusserre, N., Stachowicz, M.-L., Lea, M., Dupuy, J.-W., Vial, A., Molinari, M., Fricain, J.-C., Paris, F., & Oliveira, H. (2024). 3D bioprinted breast cancer model reveals stroma-mediated modulation of extracellular matrix and radiosensitivity. Bioactive Materials, 42, 316–327. https://doi.org/10.1016/j.bioactmat.2024.08.037

 

Dijkstra, K. K., Cattaneo, C. M., Weeber, F., Chalabi, M., van de Haar, J., Fanchi, L. F., Slagter, M., van der Velden, D. L., Kaing, S., Kelderman, S., van Rooij, N., van Leerdam, M. E., Depla, A., Smit, E. F., Hartemink, K. J., de Groot, R., Wolkers, M. C., Sachs, N., Snaebjornsson, P., … Voest, E. E. (2018). Generation of tumor-reactive t cells by co-culture of peripheral blood lymphocytes and tumor organoids. Cell, 174(6), 1586–1598.e12. https://doi.org/10.1016/j.cell.2018.07.009

 

Du, L., Zheng, Z., Zhang, K., Sun, H., Lu, Y., Sun, M., Pang, M., Jiang, S., He, Y., Du, S., Zhao, H., Mao, Y., Kang, W., Ge, P., & Yang, H. (2025). Exploring personalized prediction of clinical chemotherapy efficacy and revealing tumor heterogeneity using patient-derived 3D bioprinting gastric cancer models. Molecular Cancer, 24(1), 259. https://doi.org/10.1186/s12943-025-02466-9

 

Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., Le, Q.-T., & Giaccia, A. J. (2009). Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell, 15(1), 35–44. https://doi.org/10.1016/j.ccr.2008.11.012

 

Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006). Lysyl oxidase is essential for hypoxia-induced metastasis. Nature, 440(7088), 1222–1226. https://doi.org/10.1038/nature04695

 

Flores-Torres, S., Jiang, T., Kort-Mascort, J., Yang, Y., Peza-Chavez, O., Pal, S., Mainolfi, A., Pardo, L. A., Ferri, L., Bertos, N., Sangwan, V., & Kinsella, J. M. (2023). Constructing 3D in vitro models of heterocellular solid tumors and stromal tissues using extrusion-based bioprinting. ACS Biomaterials Science & Engineering, 9(2), 542–561. https://doi.org/10.1021/acsbiomaterials.2c00998

 

Fukuda, R., Zhang, H., Kim, J. W., Shimoda, L., Dang, C. V., & Semenza, G. L. (2007). HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell, 129(1), 111–122. https://doi.org/10.1016/j.cell.2007.01.047

 

Gallez, B. (2022). The role of imaging biomarkers to guide pharmacological interventions targeting tumor hypoxia. Frontiers in Pharmacology, 13, 853568. https://doi.org/10.3389/fphar.2022.853568

 

Ganesh, K., Wu, C., O’Rourke, K. P., Szeglin, B. C., Zheng, Y., Sauvé, C.-E. G., Adileh, M., Wasserman, I., Marco, M. R., Kim, A. S., Shady, M., Sanchez-Vega, F., Karthaus, W. R., Won, H. H., Choi, S.-H., Pelossof, R., Barlas, A., Ntiamoah, P., Pappou, E., … Smith, J. J. (2019). A rectal cancer organoid platform to study individual responses to chemoradiation. Nature Medicine, 25(10), 1607–1614. https://doi.org/10.1038/s41591-019-0584-2

 

Germain, N., Dhayer, M., Dekiouk, S., & Marchetti, P. (2022). Current advances in 3D bioprinting for cancer modeling and personalized medicine. International Journal of Molecular Sciences, 23(7), 3432. https://doi.org/10.3390/ijms23073432

 

Gilkes, D. M., Semenza, G. L., & Wirtz, D. (2014). Hypoxia and the extracellular matrix: Drivers of tumour metastasis. Nature Reviews Cancer, 14(6), 430–439. https://doi.org/10.1038/nrc3726

 

Godier, C., Baka, Z., Lamy, L., Gribova, V., Marchal, P., Lavalle, P., Gaffet, E., Bezdetnaya, L., & Alem, H. (2024). A 3D bio-printed-based model for pancreatic ductal adenocarcinoma. Diseases, 12(9), 206. https://doi.org/10.3390/diseases12090206

 

Grimes, D. R., Kelly, C., Bloch, K., & Partridge, M. (2014). A method for estimating the oxygen consumption rate in multicellular tumour spheroids. Journal of the Royal Society Interface, 11(92), 20131124. https://doi.org/10.1098/rsif.2013.1124

 

Grün, C., Nies, C., Klesen, M., Schwarz, E., ter Haseborg, J., Dettmer, C., Beyer, C., Funk, L., & Gottwald, E. (2026). High-throughput analysis of 3D cell culture oxygen consumption using sensor arrays: A novel platform for hypoxia/normoxia research. Organoids, 5(1), 5. https://doi.org/10.3390/organoids5010005

 

Horder, H., Böhringer, D., Endrizzi, N., Hildebrand, L. S., Cianciosi, A., Stecher, S., Dusi, F., Schweinitzer, S., Watzling, M., Groll, J., Jüngst, T., Teßmar, J., Bauer-Kreisel, P., Fabry, B., & Blunk, T. (2024). Cancer cell migration depends on adjacent ASC and adipose spheroids in a 3D bioprinted breast cancer model. Biofabrication, 16(3), 035031. https://doi.org/10.1088/1758-5090/ad57f7

 

Horder, H., Guaza Lasheras, M., Grummel, N., Nadernezhad, A., Herbig, J., Ergün, S., Teßmar, J., Groll, J., Fabry, B., Bauer-Kreisel, P., & Blunk, T. (2021). Bioprinting and differentiation of adipose-derived stromal cell spheroids for a 3D breast cancer-adipose tissue model. Cells, 10(4), 803. https://doi.org/10.3390/cells10040803

 

Isik, S., Yucel, D., & Hasirci, V. (2026). Modeling a hypoxia-integrated glioblastoma microenvironment to mimic tumor heterogeneity and chemoresistance. Biomaterials Science, 14(15), 3963–3981. https://doi.org/10.1039/d5bm01824b

 

Iuele, H., Forciniti, S., Onesto, V., Colella, F., Siciliano, A. C., Chandra, A., Nobile, C., Gigli, G., & Del Mercato, L. L. (2024). Facile one pot synthesis of hybrid core-shell silica-based sensors for live imaging of dissolved oxygen and hypoxia mapping in 3D cell models. ACS Applied Materials & Interfaces, 16(41), 55071–55085. https://doi.org/10.1021/acsami.4c08306

 

Jaakkola, P., Mole, D. R., Tian, Y. M., Wilson, M. I., Gielbert, J., Gaskell, S. J., von Kriegsheim, A., Hebestreit, H. F., Mukherji, M., Schofield, C. J., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001). Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science, 292(5516), 468–472. https://doi.org/10.1126/science.1059796

 

Jung, M., Ghamrawi, S., Du, E. Y., Gooding, J. J., & Kavallaris, M. (2022). Advances in 3D bioprinting for cancer biology and precision medicine: From matrix design to application. Advanced Healthcare Materials, 11(24), 2200690. https://doi.org/10.1002/adhm.202200690

 

Keeley, T. P., & Mann, G. E. (2019). Defining physiological normoxia for improved translation of cell physiology to animal models and humans. Physiological Reviews, 99(1), 161–234. https://doi.org/10.1152/physrev.00041.2017

 

Khurana, T., Thomas, S., Sudhakar, S., Edwards, S. M., Bearon, R. N., & Raj M, K. (2026). Drug transport in spheroids on a microfluidic tumor-on-chip platform: An integrated computational and experimental study. Biomicrofluidics, 20(4), 044105. https://doi.org/10.1063/5.0339813

 

Kim, J. W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006). HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metabolism, 3(3), 177–185. https://doi.org/10.1016/j.cmet.2006.02.002

 

Knobloch-Sperlich, D., Kappler, M., Glaß, M., Güttler, A., Petrenko, M., Pyko, J., Gutschner, T., Tavasol, F., Vordermark, D., & Bache, M. (2026). Two-color spheroid model for determining the O2-induced radiosensitivity of HNSCC. Journal of Biological Engineering, 20(1), 17. https://doi.org/10.1186/s13036-025-00611-y

 

Krajewska, U., Chechlińska, M., & Kurzyk, A. (2026). Vascularisation in 3D bioprinted models: Emerging solutions engineering functional tissues and tumour models. Biofabrication, 18(2), 022001. https://doi.org/10.1088/1758-5090/ae2f02

 

Lansche, C., Ladaigue, S., Gropplero, G., Zimmermann, N., Nurmik, M., Veith, I., Nguyen, M.-L., Brosseau, S., Poté, N., Mordant, P., Roussel, A., Mami-Chouaib, F., Mechta-Grigoriou, F., Zalcman, G., Soncin, F., Descroix, S., & Parrini, M. C. (2025). Bioengineering a patient‐derived vascularized lung tumor‐on‐chip model to decipher immunomodulation by the endothelium. Advanced Healthcare Materials, 14(25), 2403446. https://doi.org/10.1002/adhm.202403446

 

Lee, D., Lee, S.-H., Jung, Y., Lee, J., Choi, M.-S., Oh, S., Kim, S., Kim, B. S., & Jeong, S. (2026). Microenvironment‐guided evolution of ssdna‐swcnt probes for selective recognition of aggressive prostate cancer phenotypes. Advanced Science (Weinh), 13(17), e18582. https://doi.org/10.1002/advs.202518582

 

Li, M., Freeman, S., Franco-Barraza, J., Cai, K. Q., Kim, A., Jin, S., Cukierman, E., & Ye, K. (2024). A bioprinted sea-and-island multicellular model for dissecting human pancreatic tumor-stroma reciprocity and adaptive metabolism. Biomaterials, 310, 122631. https://doi.org/10.1016/j.biomaterials.2024.122631

 

Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., Hjelmeland, A. B., & Rich, J. N. (2009). Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell, 15(6), 501–513. https://doi.org/10.1016/j.ccr.2009.03.018

 

Mao, S., He, J., Zhao, Y., Liu, T., Xie, F., Yang, H., Mao, Y., Pang, Y., & Sun, W. (2020). Bioprinting of patient-derived in vitro intrahepatic cholangiocarcinoma tumor model: Establishment, evaluation and anti-cancer drug testing. Biofabrication, 12(4), 045014. https://doi.org/10.1088/1758-5090/aba0c3

 

Molley, T. G., Jiang, S., Ong, L., Kopecky, C., Ranaweera, C. D., Jalandhra, G. K., Milton, L., Kardia, E., Zhou, Z., Rnjak-Kovacina, J., Waters, S. A., Toh, Y.-C., & Kilian, K. A. (2023). Gas-modulating microcapsules for spatiotemporal control of hypoxia. Proceedings of the National Academy of Sciences of the United States of America, 120(16), e2217557120. https://doi.org/10.1073/pnas.2217557120

 

Mukomoto, R., Nashimoto, Y., Terai, T., Imaizumi, T., Hiramoto, K., Ino, K., Yokokawa, R., Miura, T., & Shiku, H. (2020). Oxygen consumption rate of tumour spheroids during necrotic-like core formation. Analyst, 145(19), 6342–6348. https://doi.org/10.1039/d0an00979b

 

Nasiri, R., Kurosu Jalil, M., Ibanez Gaspar, V., Flores Perez, A. S., Nguyen, H. T. M., Khan, S., Tang, S. K. Y., Yang, Y. P., & Pratx, G. (2025). A lung tumor-on-a-chip model recapitulates the effect of hypoxia on radiotherapy response and FDG-PET imaging. Lab on a Chip, 25(18), 4677–4691. https://doi.org/10.1039/d5lc00373c

 

Nasri, D., Manwar, R., Kaushik, A., Er, E. E., & Avanaki, K. (2023). Photoacoustic imaging for investigating tumor hypoxia: A strategic assessment. Theranostics, 13(10), 3346–3367. https://doi.org/10.7150/thno.84253

 

Neufeld, L., Yeini, E., Pozzi, S., & Satchi-Fainaro, R. (2022). 3D bioprinted cancer models: From basic biology to drug development. Nature Reviews Cancer, 22(12), 679–692. https://doi.org/10.1038/s41568-022-00514-w

 

Ning, L., Shim, J., Tomov, M. L., Liu, R., Mehta, R., Mingee, A., Hwang, B., Jin, L., Mantalaris, A., Xu, C., Mahmoudi, M., Goldsmith, K. C., & Serpooshan, V. (2022). A 3D bioprinted in vitro model of neuroblastoma recapitulates dynamic tumor‐endothelial cell interactions contributing to solid tumor aggressive behavior. Advanced Science (Weinh), 9(23), 2200244. https://doi.org/10.1002/advs.202200244

 

Nordsmark, M., Bentzen, S. M., Rudat, V., Brizel, D., Lartigau, E., Stadler, P., Becker, A., Adam, M., Molls, M., Dunst, J., Terris, D. J., & Overgaard, J. (2005). Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. an international multi-center study. Radiotherapy and Oncology, 77(1), 18–24. https://doi.org/10.1016/j.radonc.2005.06.038

 

Oh, J. M., Begum, H. M., Liu, Y. L., Ren, Y., & Shen, K. (2022). Recapitulating tumor hypoxia in a cleanroom-free, liquid-pinning-based microfluidic tumor model. ACS Biomaterials Science & Engineering, 8(7), 3107–3121. https://doi.org/10.1021/acsbiomaterials.2c00207

 

Okkelman, I. A., Vercruysse, C., Kondrashina, A. V., Borisov, S. M., & Dmitriev, R. I. (2022). Affordable oxygen microscopy-assisted biofabrication of multicellular spheroids. Journal of Visualized Experiments, (182), e63403. https://doi.org/10.3791/63403

 

Ooft, S. N., Weeber, F., Dijkstra, K. K., McLean, C. M., Kaing, S., van Werkhoven, E., Schipper, L., Hoes, L., Vis, D. J., van de Haar, J., Prevoo, W., Snaebjornsson, P., van der Velden, D., Klein, M., Chalabi, M., Boot, H., van Leerdam, M., Bloemendal, H. J., Beerepoot, L. V., … Voest, E. E. (2019). Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients. Science Translational Medicine, 11(513), eaay2574. https://doi.org/10.1126/scitranslmed.aay2574

 

Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006). HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metabolism, 3(3), 187–197. https://doi.org/10.1016/j.cmet.2006.01.012

 

Park, W., Bae, M., Hwang, M., Jang, J., Cho, D. W., & Yi, H. G. (2021). 3D cell-printed hypoxic cancer-on-a-chip for recapitulating pathologic progression of solid cancer. Journal of Visualized Experiments, (167), e61945. https://doi.org/10.3791/61945

 

Parodi, I., Palamà, M. E. F., Di Lisa, D., Pastorino, L., Lagazzo, A., Falleroni, F., Aiello, M., Fato, M. M., & Scaglione, S. (2025). Core-shell hydrogels with tunable stiffness for breast cancer tissue modelling in an organ-on-chip system. Gels, 11(5), 356. https://doi.org/10.3390/gels11050356

 

Poljak, I., Chiappini, C., & Adriani, G. (2026). Engineering perfusion to meet tumor biology: Are vascularized tumor-on-a-chip models ready to drive therapy innovation? Lab on a Chip, 26(5), 1162–1190. https://doi.org/10.1039/d5lc01060h

 

Pyne, E., Reardon, M., Christensen, M., Rodriguez Mateos, P., Taylor, S., Iles, A., Choudhury, A., Pamme, N., & Pires, I. M. (2024). Investigating the impact of the interstitial fluid flow and hypoxia interface on cancer transcriptomes using a spheroid-on-chip perfusion system. Lab on a Chip, 24(19), 4609–4622. https://doi.org/10.1039/d4lc00512k

 

Quail, D. F., & Joyce, J. A. (2013). Microenvironmental regulation of tumor progression and metastasis. Nature Medicine, 19(11), 1423–1437. https://doi.org/10.1038/nm.3394

 

Rafik, S. T., Ho, J., MacRobert, A. J., & Cheema, U. (2026). Engineering complex breast tumor-stroma models: TMPyP4-photodynamic therapy is more effective at the metastatic site in breast tumors. ACS Biomaterials Science & Engineering, 12(1), 515–530. https://doi.org/10.1021/acsbiomaterials.5c01341

 

Ramos, L., Robinson, M., Lallous, N., Flannigan, R., & Daugaard, M. (2026). Recent advances in purpose-built 3D bioprinted cancer models for drug development. Expert Opinion on Drug Discovery, 21(5), 475–490. https://doi.org/10.1080/17460441.2026.2642320

 

Refet-Mollof, E., Najyb, O., Chermat, R., Glory, A., Lafontaine, J., Wong, P., & Gervais, T. (2021). Hypoxic jumbo spheroids on-a-chip (honachip): Insights into treatment efficacy. Cancers (Basel), 13(16), 4046. https://doi.org/10.3390/cancers13164046

 

Ruan, Y., He, L., Chen, J., Wang, J., Zhao, S., Guo, X., Xie, Y., Cai, Z., Shen, X., & Li, C. (2023). Three-dimensional core-shell alginate microsphere for cancer hypoxia simulation in vitro. Frontiers in Bioengineering and Biotechnology, 11, 1174206. https://doi.org/10.3389/fbioe.2023.1174206

 

Schito, L., & Rey-Keim, S. (2026). HyPIC-3D enables characterization of migratory cancer cell subpopulations in 3D hypoxic microenvironments. Cell Reports Methods, 6(6), 101454. https://doi.org/10.1016/j.crmeth.2026.101454

 

Schito, L., & Semenza, G. L. (2016). Hypoxia-inducible factors: Master regulators of cancer progression. Trends in Cancer, 2(12), 758–770. https://doi.org/10.1016/j.trecan.2016.10.016

 

Seidel, S., Garvalov, B. K., Wirta, V., von Stechow, L., Schänzer, A., Meletis, K., Wolter, M., Sommerlad, D., Henze, A.-T., Nistér, M., Reifenberger, G., Lundeberg, J., Frisén, J., & Acker, T. (2010). A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2α. Brain, 133(4), 983–995. https://doi.org/10.1093/brain/awq042

 

Shi, T. H., Huang, Y.-T., Jeon, H., Montes-Pinzon, D., Chang, P. M.-H., Chiang, N.-J., Sinclair, J. A., Taglione, A., Hanjaya-Putra, D., Wang, Y., Huang, C.-Y. F., & Chang, H.-C. (2026). Hypoxia-induced drug-resistance bias 3D cancer spheroid drug screens. APL Bioengineering, 10(1), 016113. https://doi.org/10.1063/5.0304565

 

Shirure, V. S., Bi, Y., Curtis, M. B., Lezia, A., Goedegebuure, M. M., Goedegebuure, S. P., Aft, R., Fields, R. C., & George, S. C. (2018). Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids. Lab on a Chip, 18(23), 3687–3702. https://doi.org/10.1039/c8lc00596f

 

Shukla, P., Bera, A. K., Yeleswarapu, S., & Pati, F. (2024). High throughput bioprinting using decellularized adipose tissue‐based hydrogels for 3D breast cancer modeling. Macromolecular Bioscience, 24(8), e2400035. https://doi.org/10.1002/mabi.202400035

 

Shukla, P., Yeleswarapu, S., Heinrich, M. A., Prakash, J., & Pati, F. (2022). Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling. Biofabrication, 14(3), 032002. https://doi.org/10.1088/1758-5090/ac6d11

 

Singleton, D. C., Macann, A., & Wilson, W. R. (2021). Therapeutic targeting of the hypoxic tumour microenvironment. Nature Reviews Clinical Oncology, 18(12), 751–772. https://doi.org/10.1038/s41571-021-00539-4

 

Skubal, M., Larney, B. M., Phung, N. B., Desmaras, J. C., Dozic, A. V., Volpe, A., Ogirala, A., Machado, C. L., Djibankov, J., Ponomarev, V., & Grimm, J. (2025). Vascularized tumor on a microfluidic chip to study mechanisms promoting tumor neovascularization and vascular targeted therapies. Theranostics, 15(3), 766–783. https://doi.org/10.7150/thno.95334

 

Sobrino, A., Phan, D. T. T., Datta, R., Wang, X., Hachey, S. J., Romero-López, M., Gratton, E., Lee, A. P., George, S. C., & Hughes, C. C. W. (2016). 3D microtumors in vitro supported by perfused vascular networks. Scientific Reports, 6(1), 31589. https://doi.org/10.1038/srep31589

 

Sun, H., Wang, Y., Sun, M., Ke, X., Li, C., Jin, B., Pang, M., Wang, Y., Jiang, S., Du, L., Du, S., Zhong, S., Zhao, H., Pang, Y., Sun, Y., Yang, Z., Yang, H., & Mao, Y. (2025). Developing patient-derived 3D-bioprinting models of pancreatic cancer. Journal of Advanced Research, 74, 165–174. https://doi.org/10.1016/j.jare.2024.09.011

 

Talks, K. L., Turley, H., Gatter, K. C., Maxwell, P. H., Pugh, C. W., Ratcliffe, P. J., & Harris, A. L. (2000). The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages. American Journal of Pathology, 157(2), 411–421. https://doi.org/10.1016/s0002-9440(10)64554-3

 

Tang, G., Peng, Z., Zhao, Y., Chen, X., Huang, S., Chen, G., & Guo, W. (2026). A vascularized 3D-bioprinted model of the osteosarcoma microenvironment reveals a proliferation-to-invasion switch that confers chemoresistance. International Journal of Bioprinting, 12(2), 026040031. https://doi.org/10.36922/ijb026040031

 

Telarovic, I., Wenger, R. H., & Pruschy, M. (2021). Interfering with tumor hypoxia for radiotherapy optimization. Journal of Experimental & Clinical Cancer Research, 40(1), 197. https://doi.org/10.1186/s13046-021-02000-x

 

Terrassoux, L., Hazard, C., Laratte, A., Balsamelli, J., Arcicasa, M., Fong, E., Baland, L., Soncin, F., Cappello, G., Maurage, C.-A., Janel, S., Bazir, A., Cleri, F., Treizebre, A., Lartigau, E., Rekik, Y., Meignan, S., & Furlan, A. (2025). Novel diffuse midline glioma‐on‐chip recapitulating tumor biophysical microenvironment to assess the heterogeneity of response to therapies. Small, 21(45), e05343. https://doi.org/10.1002/smll.202505343

 

Tiriac, H., Belleau, P., Engle, D. D., Plenker, D., Deschênes, A., Somerville, T. D. D., Froeling, F. E. M., Burkhart, R. A., Denroche, R. E., Jang, G.-H., Miyabayashi, K., Young, C. M., Patel, H., Ma, M., LaComb, J. F., Palmaira, R. L. D., Javed, A. A., Huynh, J. C., Johnson, M., … Tuveson, D. A. (2018). Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discovery, 8(9), 1112–1129. https://doi.org/10.1158/2159-8290.cd-18-0349

 

Vlachogiannis, G., Hedayat, S., Vatsiou, A., Jamin, Y., Fernández-Mateos, J., Khan, K., Lampis, A., Eason, K., Huntingford, I., Burke, R., Rata, M., Koh, D.-M., Tunariu, N., Collins, D., Hulkki-Wilson, S., Ragulan, C., Spiteri, I., Moorcraft, S. Y., Chau, I., … Valeri, N. (2018). Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science, 359(6378), 920–926. https://doi.org/10.1126/science.aao2774

 

Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995). Hypoxia-inducible factor 1 is a basic-helix-loop-helix-pas heterodimer regulated by cellular O2 tension. Proceedings of the National Academy of Sciences of the United States of America, 92(12), 5510–5514. https://doi.org/10.1073/pnas.92.12.5510

 

Wicks, E. E., & Semenza, G. L. (2022). Hypoxia-inducible factors: Cancer progression and clinical translation. Journal of Clinical Investigation, 132(11), e159839. https://doi.org/10.1172/jci159839

 

Wong, C. C. L., Gilkes, D. M., Zhang, H., Chen, J., Wei, H., Chaturvedi, P., Fraley, S. I., Wong, C.-M., Khoo, U.-S., Ng, I. O.-L., Wirtz, D., & Semenza, G. L. (2011). Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation. Proceedings of the National Academy of Sciences of the United States of America, 108(39), 16369–16374. https://doi.org/10.1073/pnas.1113483108

 

Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J. (2008). Direct regulation of TWIST by HIF-1α promotes metastasis. Nature Cell Biology, 10(3), 295–305. https://doi.org/10.1038/ncb1691

 

Yao, E. J., Lu, G. Y., Vadla, R., Xiang, Y., Lu, T.-Y., Sun, Y., Berman, E. L., Zhang, N., Furnari, F., & Chen, S. (2026). Forming a precise and reproducible hypoxic tumor microenvironment in glioblastoma by high cell density bioprinting. Advanced Healthcare Materials, 15(26), e71322. https://doi.org/10.1002/adhm.71322

 

Yi, H.-G., Jeong, Y.-H., Kim, Y., Choi, Y.-J., Moon, H. E., Park, S. H., Kang, K. S., Bae, M., Jang, J., Youn, H., Paek, S. H., & Cho, D.-W. (2019). A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy. Nature Biomedical Engineering, 3(7), 509–519. https://doi.org/10.1038/s41551-019-0363-x

 

Ziółkowska-Suchanek, I. (2021). Mimicking tumor hypoxia in non-small cell lung cancer employing three-dimensional in vitro models. Cells, 10(1), 141. https://doi.org/10.3390/cells10010141

Share
Back to top
Hypoxia & Medicine, Published by AccScience Publishing